The Canadian childhood nephrotic syndrome (CHILDNEPH) study: report on mid-study feasibility, recruitment and main measures-Reference-Cited by-同舟云学术

The Canadian childhood nephrotic syndrome (CHILDNEPH) study: report on mid-study feasibility, recruitment and main measures

Published:2019-05-14 Issue:1 Volume:20 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Samuel Susan M.^ORCID, ,Dart Allison,Filler Guido,Bitzan Martin,Pinsk Maury,Mammen Cherry,Nettel-Aguirre Alberto,Perinpanayagam Maneka A.,Takano Tomoko,Chanchlani Rahul,Zappitelli Michael

Funder

Canadian Institutes of Health Research

Kidney Foundation of Canada

Nephcure Foundation

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-019-1320-3.pdf

Reference18 articles.

1. Noone DG, Iijima K, Parekh R. Idiopathic nephrotic syndrome in children. Lancet. 2018;392(10141):61–74.

2. Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362(9384):629–39.

3. Sinha A, Hari P, Sharma PK, et al. Disease course in steroid sensitive nephrotic syndrome. Indian Pediatr. 2012;49(11):881–7.

4. Ayoob RM, Hains DS, Smoyer WE. Trends in hospitalization characteristics for pediatric nephrotic syndrome in the USA. Clin Nephrol. 2012;78(2):106–11.

5. Gipson DS, Massengill SF, Yao L, et al. Management of childhood onset nephrotic syndrome. Pediatrics. 2009;124(2):747–57.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The urgent need for conducting clinical trials in pediatric nephrology globally;Pediatric Nephrology;2023-02-04

2. Steroid Sensitive Nephrotic Syndrome;Pediatric Kidney Disease;2023

3. Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions;Pediatric Nephrology;2022-04-28

4. Practice of Childhood Nephrotic Syndrome Management amongPediatric Nephrologists in the GCC Countries;Saudi Journal of Kidney Diseases and Transplantation;2021

5. Appreciating the Impact of Tacrolimus Sampling Time Deviations in Pediatric Patients With Nephrotic Syndrome;Therapeutic Drug Monitoring;2020-06